Related Laws Explorer

Elijah's Law

This bill establishes food allergy safety and anaphylaxis response protocols in licensed child care centers and family day care homes.

Allows individuals with personal epinephrine prescriptions to administer to others in emergencies.

NJ Menu Allergen Disclosure Bill

Requires food service businesses to provide clear and conspicuous written notice of major food allergens (as defined by 21 U.S.C. 321(qq)) that the business knows or reasonably should know are contained as ingredients in each menu item, including temporary menu items. Information may be provided on the menu, via a QR code linking to a website, or on other written materials (separate menu, chart, grid, or booklet). Businesses must use common/usual allergen names or standardized icons approved by the Commissioner of Health. Exempts prepackaged foods subject to federal labeling. The Commissioner of Health shall adopt rules and regulations to implement. Takes effect the first day of the 13th month after enactment.

New Jersey Restaurant Allergen Disclosure Act (S.3394/A.4826)

S.3394/A.4826 requires New Jersey food service businesses to provide clear and conspicuous written notice of major food allergens (the top 9) that they know or reasonably should know are contained in each menu item, including temporary menu items. Disclosure may be on the menu, via a QR code linking to a website, or on separate written materials. More than 950,000 New Jersey residents live with food allergies, yet restaurants are currently not required to clearly disclose allergens.

This bill expands the types of epinephrine devices permitted in schools and camps to include nasal sprays.

Allows trained school bus drivers to administer epinephrine to students.

Massachusetts Stock Epinephrine Bill

This pending bill would require all schools to maintain a stock supply of non-patient specific epinephrine auto-injectors. It mandates that the Department of Public Health create regulations for storage in unlocked locations and staff training.

Epinephrine Delivery Systems Update

A pending bill that updates existing school health statutes to replace the term 'epinephrine auto-injectors' with 'epinephrine delivery systems.' This change is intended to allow schools to stock newer, needle-free epinephrine options such as nasal sprays.

School Epinephrine Administration Expansion Bill

Legislative bill to explicitly codify into the General Laws the authority for school districts and non-public schools to register to train unlicensed school personnel to administer epinephrine auto-injectors during school hours and school-sponsored events when a nurse is not immediately available.

Elijah's Law

Establishes 'Elijah's Law' for Missouri, requiring licensed child care facilities to adopt allergy prevention and emergency response policies, and explicitly adds child care facilities to authorized entities allowed to acquire and stock epinephrine auto-injectors.

Needle Free Epinephrine Bill

Proposed legislation to update existing statutes to explicitly allow the use of epinephrine nasal sprays in addition to auto-injectors in school settings.

Proposes authorizing child care facilities to maintain a stock supply of epinephrine and train designated personnel to administer it in emergencies.

Safe Step Act

Requires group health plans to establish a transparent exceptions process (24-72 hours) for step therapy protocols, allowing doctors to override insurer fail-first requirements when medically necessary.

SponsorSen. Tammy Baldwin (D-WI), Rep. Lucy McBath (D-GA) (Bipartisan)

HELP Copays Act

Bans copay accumulator adjustment policies that prevent manufacturer copay assistance from counting toward patient deductibles and out-of-pocket maximums.

SponsorSen. Roger Marshall (R-KS) (Bipartisan)

Chronic Disease Flexible Coverage Act

Expands coverage options for individuals with chronic diseases including asthma by allowing states to offer targeted chronic disease coverage plans outside of traditional open enrollment.

New York Asthma Inhaler Coverage Act (S.3100A)

S.3100A expands New York insurance coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children. New Yorkers with asthma can face large financial barriers to drugs that hinder optimal treatment; high out-of-pocket costs hinder adherence, threaten patient health, and exacerbate health disparities. The bill passed the Senate 59-2 on March 17, 2025 and was reported and committed to the Finance Committee on May 12, 2026.

Federal bill to cap the cost of life-saving epinephrine injectors by establishing cost-sharing requirements under group health plans and health insurance coverage.

Requires private health insurers to provide epinephrine products without deductibles, copayments, or coinsurance.